Engineers Gate Manager’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Engineers Gate Manager’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,509	Closed	-$20.4K	–	2407
2023 Q4	$20.4K	Buy	+1,509	New	+$24.5K	﹤0.01%	1905
2022 Q3	–	Sell	-46	Closed	-$8K	–	2225
2022 Q2	$8K	Hold	46	–	–	﹤0.01%	1848
2022 Q1	$13K	Sell	46 -222	-83%	-$84.2K	﹤0.01%	1784
2021 Q4	$140K	Buy	+268	New	+$192K	0.01%	1748
2021 Q2	–	Sell	-47	Closed	-$55K	–	2160
2021 Q1	$55K	Buy	+47	New	+$64.8K	﹤0.01%	1741

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Engineers Gate Manager's BIOR Position: Q1 2024 in Review

Engineers Gate Manager sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2024, closing a stake of 1,509 shares — an estimated $20.4K sold.

Engineers Gate Manager first reported a position in BIOR in Q1 2021 and held it in 5 quarters. The position peaked at $140K in Q4 2021. 27 funds tracked by Wall St. Rank hold BIOR as of Q1 2024.

Engineers Gate Manager reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Engineers Gate Manager sold 1,509 Biora Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $20.4K.
Engineers Gate Manager first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Engineers Gate Manager's Biora Therapeutics, Inc. Common Stock position peaked at $140K in Q4 2021.
27 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.